Fredericksen, R. J. https://orcid.org/0000-0003-3936-7048
Whitney, B. M.
Trejo, E.
Nance, R. M.
Fitzsimmons, E.
Altice, F. L.
Carrico, A. W.
Cleland, C. M.
Del Rio, C.
Duerr, A.
El-Sadr, W. M.
Kahana, S.
Kuo, I.
Mayer, K.
Mehta, S.
Ouellet, L. J.
Quan, V. M.
Rich, J.
Seal, D. W.
Springer, S.
Taxman, F.
Wechsberg, W.
Crane, H. M.
Delaney, J. A. C.
Funding for this research was provided by:
National Institute on Drug Abuse (U01DA037702)
National Institute on Drug Abuse (BCAP1 R01DA032083)
National Institute on Drug Abuse (BRIGHT1 R01DA030771)
National Institute on Drug Abuse (STAR R01DA032100)
National Institute on Drug Abuse (STTS R01DA030796)
Article History
Received: 8 June 2020
Accepted: 15 October 2021
First Online: 4 November 2021
Declarations
:
: Human subject research approval for this research was obtained via the each associated institution’s Institutional Review Board: Written informed consent was obtained from all study participants.
: Not applicable.
: S. Springer received consultation payment from Alkermes Inc. for scientific expertise consulting. No other disclosures.